These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2561098

  • 1. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours.
    Harding MJ, Brown IL, MacPherson SG, Turner MA, Kaye SB.
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1689-94. PubMed ID: 2561098
    [Abstract] [Full Text] [Related]

  • 2. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
    Tait D, Peckham MJ, Hendry WF, Goldstraw P.
    Br J Cancer; 1984 Nov; 50(5):601-9. PubMed ID: 6093838
    [Abstract] [Full Text] [Related]

  • 3. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A, Clemm C, Schmeller N, Dienemann H, Weiss M, Kriegmair M, Löhrs U, Wilmanns W.
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [Abstract] [Full Text] [Related]

  • 4. Complications of the post-chemotherapy resection of retroperitoneal residual tumour mass in patients with non-seminomatous testicular germ cell tumours.
    Gels ME, Nijboer AP, Hoekstra HJ, Sleijfer DT, Molenaar WM, Plukker JT, Droste JH, Schraffordt Koops H.
    Br J Urol; 1997 Feb; 79(2):263-8. PubMed ID: 9052480
    [Abstract] [Full Text] [Related]

  • 5. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM, Escaf Barmadah S, Guate Ortiz JL, Martín Huescar A, Fresno Forcelledo F, García Rodríguez J, Rodríguez Faba O, Jalón Monzón A, Rodríguez Martínez JJ.
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [Abstract] [Full Text] [Related]

  • 6. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
    Horvath LG, McCaughan BC, Stockle M, Boyer MJ.
    Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G, Salvioni R, Pasi M, Zanoni F, Milani A, Pilotti S, Monfardini S.
    Cancer; 1985 Jul 15; 56(2):249-55. PubMed ID: 2408728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Non-seminomatous germ cell testicular tumours: residual masses after chemotherapy.
    Levitt MD, Reynolds PM, Sheiner HJ, Byrne MJ.
    Br J Surg; 1985 Jan 15; 72(1):19-22. PubMed ID: 2578300
    [Abstract] [Full Text] [Related]

  • 11. The extent of surgery after chemotherapy for advanced germ cell tumors.
    Freiha FS, Shortliffe LD, Rouse RV, Mark JB, Hannigan JF, Aston D, Spaulding JT, Williams RD, Torti FM.
    J Urol; 1984 Nov 15; 132(5):915-7. PubMed ID: 6208386
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW, Toner GC, Geller NL, Bosl GJ.
    Eur Urol; 1991 Nov 15; 19(1):1-5. PubMed ID: 1848821
    [Abstract] [Full Text] [Related]

  • 14. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors.
    Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C.
    Ann Oncol; 1997 Jun 15; 8(6):531-8. PubMed ID: 9261521
    [Abstract] [Full Text] [Related]

  • 15. Failure of salvage treatment in metastatic testicular teratoma.
    Whillis D, Coleman RE, Cornbleet MA, Howard GC.
    Clin Oncol (R Coll Radiol); 1991 May 15; 3(3):141-6. PubMed ID: 1712626
    [Abstract] [Full Text] [Related]

  • 16. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
    Loehrer PJ, Hui S, Clark S, Seal M, Einhorn LH, Williams SD, Ulbright T, Mandelbaum I, Rowland R, Donohue JP.
    J Urol; 1986 Jun 15; 135(6):1183-9. PubMed ID: 2423708
    [Abstract] [Full Text] [Related]

  • 17. [Exeresis of residual masses of germinal tumors of the testis after chemotherapy].
    Bassoulet J, du Chatelard P, Auberget JL, Merrer J, Guillemot MC, Timbal Y.
    Ann Urol (Paris); 1989 Jun 15; 23(5):388-92. PubMed ID: 2560360
    [Abstract] [Full Text] [Related]

  • 18. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
    Loehrer PJ, Mandelbaum I, Hui S, Clark S, Einhorn LH, Williams SD, Donohue JP.
    J Thorac Cardiovasc Surg; 1986 Oct 15; 92(4):676-83. PubMed ID: 3020319
    [Abstract] [Full Text] [Related]

  • 19. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
    Antonelli L, Ardizzone D, Ravi P, Bagrodia A, Mego M, Daneshmand S, Nicolai N, Nazzani S, Giannatempo P, Franza A, Heidenreich A, Paffenholz P, Saoud R, Eggener S, Ho M, Oswald N, Olson K, Tryakin A, Fedyanin M, Naoun N, Javaud C, Fizazi K, King JM, Adra N, Douglawi A, Cary C, Sweeney C, Fankhauser CD.
    Eur J Cancer; 2023 Mar 15; 182():144-154. PubMed ID: 36787661
    [Abstract] [Full Text] [Related]

  • 20. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
    Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD.
    J Clin Oncol; 2003 Sep 01; 21(17):3310-7. PubMed ID: 12947067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.